Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T19:48:19.522Z.
Calculation as of: 2026-10-06T19:48:19.522Z.
Quote observation: 2026-10-06T19:45:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 47811cd6fce140e68777d2609bf88a35ade871fb75fdb0cf4ca3c33c868081b2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
Medicus Pharma Ltd. Common Stock
Market Cap
$10.03M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.88M
EV/Sales Ratio
429.80x
TTM Avg
943.18x
3Y Avg
346.01x
5Y Avg
219.00x
Market Cap
$10.18M
EV/Sales Ratio
N/A
TTM Avg
52.89x
3Y Avg
52.89x
5Y Avg
52.89x
Market Cap
$9.66M
EV/Sales Ratio
0.77x
TTM Avg
3.06x
3Y Avg
5.84x
5Y Avg
28.58x
Market Cap
$9.65M
EV/Sales Ratio
1620.41x
TTM Avg
683.01x
3Y Avg
535.46x
5Y Avg
1037.99x
Market Cap
$10.42M
EV/Sales Ratio
N/A
TTM Avg
30.14x
3Y Avg
54.00x
5Y Avg
56.96x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medicus Pharma Ltd. Common Stock (MDCX) | $10.03M | N/A | N/A | N/A | N/A |
| Senti Biosciences, Inc. (SNTI)vs › | $9.88M | 429.80x | 943.18x | 346.01x | 219.00x |
| Satellos Bioscience Inc. (MSLE)vs › | $10.11M | N/A | N/A | N/A | N/A |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.18M | N/A | 52.89x | 52.89x | 52.89x |
| Valion Bio, Inc. (VBIO)vs › | $9.98M | N/A | 87.23x | 46.21x | 94.29x |
| MetaVia Inc. (MTVA)vs › | $9.82M | N/A | N/A | N/A | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.66M | 0.77x | 3.06x | 5.84x | 28.58x |
| Ainos, Inc. (AIMD)vs › | $9.65M | 1620.41x | 683.01x | 535.46x | 1037.99x |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.42M | N/A | 30.14x | 54.00x | 56.96x |
| Polyrizon Ltd. (PLRZ)vs › | $10.52M | N/A | N/A | N/A | N/A |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
